Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a tim…
Medical - Devices
US, Acton [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 6.70 | 3.70 | 3.47 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -64.78 | 9.31 | 26.43 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 7.77 | 11.30 | 10.49 | |
| Cash | 6.53 | 10.74 | 10.08 | |
| Capex | 24.16 | -0.34 | -0.45 | |
| Free Cash Flow | 377.53 | 0.91 | 0.19 | |
| Revenue | -13.48 | 6.31 | 7.30 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -0.97 | 0.70 | 0.71 | |
| Operating Margin | -46.95 | 0.13 | 0.24 | |
| ROA | -50.83 | 0.02 | 0.04 | |
| ROE | -53.80 | 0.07 | 0.14 | |
| ROIC | -61.95 | 0.02 | 0.06 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of PODD is permitted for members.
5
Growth
The "Growth Entry" for the Focus of PODD is permitted for members.
6
Leverage & Liquidity